@article{Mullish:2018:10.1016/j.jhin.2018.07.037,
author = {Mullish, BH and Quraishi, MN and Segal, JP and McCune, VL and Baxter, M and Marsden, GL and Moore, D and Colville, A and Bhala, N and Iqbal, TH and Settle, C and Kontkowski, G and Hart, AL and Hawkey, PM and Williams, HR and Goldenberg, SD},
doi = {10.1016/j.jhin.2018.07.037},
journal = {J Hosp Infect},
pages = {S1--S31},
title = {The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.},
url = {http://dx.doi.org/10.1016/j.jhin.2018.07.037},
volume = {100 Suppl 1},
year = {2018}
}

Download

TY  - JOUR
AU  - Mullish,BH
AU  - Quraishi,MN
AU  - Segal,JP
AU  - McCune,VL
AU  - Baxter,M
AU  - Marsden,GL
AU  - Moore,D
AU  - Colville,A
AU  - Bhala,N
AU  - Iqbal,TH
AU  - Settle,C
AU  - Kontkowski,G
AU  - Hart,AL
AU  - Hawkey,PM
AU  - Williams,HR
AU  - Goldenberg,SD
DO  - 10.1016/j.jhin.2018.07.037
EP  - 31
PY  - 2018///
SP  - 1
TI  - The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
T2  - J Hosp Infect
UR  - http://dx.doi.org/10.1016/j.jhin.2018.07.037
UR  - https://www.ncbi.nlm.nih.gov/pubmed/30173851
VL  - 100 Suppl 1
ER  - 

Download